AltMountain

Drug Royalties Solutions Fund LLC

New York, NY · CIK 1798418
Status: no Form D since Jan 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Drug Royalties Solutions Fund LLC is a private equity fund based in New York, New York. According to its most recent Form D, filed Jan 9, 2020, it has sold $17,875,000 of interests to 23 investors since its first sale in Dec 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include James Rothwell.

Total raised
$17,875,000Cumulative sales reported on Form D
Investors
23
First sale
Dec 27, 2019
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
James Rothwell
Latest Form D
Jan 9, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Questions about Drug Royalties Solutions Fund LLC

What is the minimum investment for Drug Royalties Solutions Fund LLC?

Drug Royalties Solutions Fund LLC's latest Form D, filed Jan 9, 2020, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Drug Royalties Solutions Fund LLC?

Drug Royalties Solutions Fund LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Drug Royalties Solutions Fund LLC raised?

Drug Royalties Solutions Fund LLC reports $17,875,000 sold from 23 investors on its Form D filed Jan 9, 2020. This is cumulative sales since the offering began, not current assets or performance.

Where is Drug Royalties Solutions Fund LLC based?

Drug Royalties Solutions Fund LLC is based in New York, New York.

When did Drug Royalties Solutions Fund LLC launch?

Drug Royalties Solutions Fund LLC reports its first sale in Dec 2019.

Size compared with every private equity fund

Raised more than 62% of the 3,670 private equity funds based in New York, and more than 50% of all 8,975 that report sales.

More private equity funds in New York

Similar-size private equity funds in New York

All private equity funds in New York